de Groene Gerda J, Pal Teake M, Beach Jeremy, Tarlo Susan M, Spreeuwers Dick, Frings-Dresen Monique Hw, Mattioli Stefano, Verbeek Jos H
Netherlands Center of Occupational Diseases, Coronel Institute of Occupational Health, Academic Medical Center, PO Box 22660, Amsterdam, Netherlands, 1100 DD.
Cochrane Database Syst Rev. 2011 May 11(5):CD006308. doi: 10.1002/14651858.CD006308.pub3.
The impact of workplace interventions on the outcome of occupational asthma is not well-understood.
To evaluate the effectiveness of workplace interventions on the outcome of occupational asthma.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL); MEDLINE; EMBASE; NIOSHTIC-2; CISDOC and HSELINE up to February 2011.
Randomised controlled trials, controlled before and after studies and interrupted time series of workplace interventions for occupational asthma.
Two authors independently assessed study eligibility and trial quality, and extracted data.
We included 21 controlled before and after studies with 1447 participants that reported on 29 comparisons.In 15 studies, removal from exposure was compared with continued exposure. Removal increased the likelihood of reporting absence of symptoms (risk ratio (RR) 21.42, 95% confidence interval (CI) 7.20 to 63.77), improved forced expiratory volume (FEV1 %) (mean difference (MD) 5.52 percentage points, 95% CI 2.99 to 8.06) and decreased non-specific bronchial hyper-reactivity (standardised mean difference (SMD) 0.67, 95% CI 0.13 to 1.21).In six studies, reduction of exposure was compared with continued exposure. Reduction increased the likelihood of reporting absence of symptoms (RR 5.35, 95% CI 1.40 to 20.48) but did not affect FEV1 % (MD 1.18 percentage points, 95% CI -2.96 to 5.32).In eight studies, removal from exposure was compared with reduction of exposure. Removal increased the likelihood of reporting absence of symptoms (RR 39.16, 95% CI 7.21 to 212.83) but did not affect FEV1 % (MD 1.16 percentage points, 95% CI -7.51 to 9.84).Two studies reported that the risk of unemployment after removal from exposure was increased compared with reduction of exposure (RR 14.3, 95% CI 2.06 to 99.16). Three studies reported loss of income of about 25% after removal from exposure.Overall the quality of the evidence was very low.
AUTHORS' CONCLUSIONS: There is very low-quality evidence that removal from exposure improves asthma symptoms and lung function compared with continued exposure.Reducing exposure also improves symptoms, but seems not as effective as complete removal.However, removal from exposure is associated with an increased risk of unemployment, whereas reduction of exposure is not. The clinical benefit of removal from exposure or exposure reduction should be balanced against the increased risk of unemployment. We need better studies to identify which interventions intended to reduce exposure give most benefit.
工作场所干预措施对职业性哮喘结局的影响尚未得到充分理解。
评估工作场所干预措施对职业性哮喘结局的有效性。
我们检索了截至2011年2月的考克兰对照试验中央注册库(CENTRAL)、医学期刊数据库(MEDLINE)、荷兰医学文摘数据库(EMBASE)、美国国家职业安全与健康研究所文献数据库(NIOSHTIC - 2)、国际劳工组织信息系统数据库(CISDOC)和英国健康与安全执行局数据库(HSELINE)。
职业性哮喘工作场所干预措施的随机对照试验、前后对照研究和中断时间序列研究。
两位作者独立评估研究的纳入资格和试验质量,并提取数据。
我们纳入了21项前后对照研究,共1447名参与者,报告了29项比较。在15项研究中,将脱离接触与继续接触进行了比较。脱离接触增加了报告无症状的可能性(风险比(RR)21.42,95%置信区间(CI)7.20至63.77),改善了用力呼气量(FEV1%)(平均差(MD)5.52个百分点,95%CI 2.99至8.06),并降低了非特异性支气管高反应性(标准化平均差(SMD)0.67,95%CI 0.13至1.21)。在6项研究中,将减少接触与继续接触进行了比较。减少接触增加了报告无症状的可能性(RR 5.35,95%CI 1.40至20.48),但未影响FEV1%(MD 1.18个百分点,95%CI -2.96至5.32)。在8项研究中,将脱离接触与减少接触进行了比较。脱离接触增加了报告无症状的可能性(RR 39.16,95%CI 7.21至212.83),但未影响FEV1%(MD 1.16个百分点,95%CI -7.51至9.84)。两项研究报告称,与减少接触相比,脱离接触后失业风险增加(RR 14.3,95%CI 2.06至99.16)。三项研究报告称,脱离接触后收入损失约25%。总体而言,证据质量非常低。
有质量非常低的证据表明,与继续接触相比,脱离接触可改善哮喘症状和肺功能。减少接触也可改善症状,但似乎不如完全脱离接触有效。然而,脱离接触与失业风险增加相关,而减少接触则不然。脱离接触或减少接触的临床益处应与增加的失业风险相权衡。我们需要更好的研究来确定哪些旨在减少接触的干预措施能带来最大益处。